Cargando…

Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle

Ageing limits growth capacity of skeletal muscle (e.g. in response to resistance exercise), but the role of satellite cell (SC) function in driving this phenomenon is poorly defined. Younger (Y) (~ 23 years) and older (O) men (~ 69 years) (normal-weight BMI) underwent 6 weeks of unilateral resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Brook, Matthew S., Wilkinson, Daniel J., Tarum, Janelle, Mitchell, Kyle W., Lund, Jonathan L., Phillips, Bethan E., Szewczyk, Nathaniel J., Kadi, Fawzi, Greenhaff, Paul L., Smith, Ken, Atherton, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886697/
https://www.ncbi.nlm.nih.gov/pubmed/36083436
http://dx.doi.org/10.1007/s11357-022-00651-y
_version_ 1784880186593902592
author Brook, Matthew S.
Wilkinson, Daniel J.
Tarum, Janelle
Mitchell, Kyle W.
Lund, Jonathan L.
Phillips, Bethan E.
Szewczyk, Nathaniel J.
Kadi, Fawzi
Greenhaff, Paul L.
Smith, Ken
Atherton, Philip J.
author_facet Brook, Matthew S.
Wilkinson, Daniel J.
Tarum, Janelle
Mitchell, Kyle W.
Lund, Jonathan L.
Phillips, Bethan E.
Szewczyk, Nathaniel J.
Kadi, Fawzi
Greenhaff, Paul L.
Smith, Ken
Atherton, Philip J.
author_sort Brook, Matthew S.
collection PubMed
description Ageing limits growth capacity of skeletal muscle (e.g. in response to resistance exercise), but the role of satellite cell (SC) function in driving this phenomenon is poorly defined. Younger (Y) (~ 23 years) and older (O) men (~ 69 years) (normal-weight BMI) underwent 6 weeks of unilateral resistance exercise training (RET). Muscle biopsies were taken at baseline and after 3-/6-week training. We determined muscle size by fibre CSA (and type), SC number, myonuclei counts and DNA synthesis (via D(2)O ingestion). At baseline, there were no significant differences in fibre areas between Y and O. RET increased type I fibre area in Y from baseline at both 3 weeks and 6 weeks (baseline: 4509 ± 534 µm(2), 3 weeks; 5497 ± 510 µm(2) P < 0.05, 6 weeks; 5402 ± 352 µm(2) P < 0.05), whilst O increased from baseline at 6 weeks only (baseline 5120 ± 403 µm(2), 3 weeks; 5606 ± 620 µm(2), 6 weeks; 6017 ± 482 µm(2) P < 0.05). However, type II fibre area increased from baseline in Y at both 3 weeks and 6 weeks (baseline: 4949 ± 459 µm(2), 3 weeks; 6145 ± 484 µm(2) (P < 0.01), 6 weeks; 5992 ± 491 µm(2) (P < 0.01), whilst O showed no change (baseline 5210 ± 410 µm(2), 3 weeks; 5356 ± 535 µm(2) (P = 0.9), 6 weeks; 5857 ± 478 µm(2) (P = 0.1). At baseline, there were no differences in fibre myonuclei number between Y and O. RET increased type I fibre myonuclei number from baseline in both Y and O at 3 weeks and 6 weeks with RET (younger: baseline 2.47 ± 0.16, 3 weeks; 3.19 ± 0.16 (P < 0.001), 6 weeks; 3.70 ± 0.29 (P < 0.0001); older: baseline 2.29 ± 0.09, 3 weeks; 3.01 ± 0.09 (P < 0.001), 6 weeks; 3.65 ± 0.18 (P < 0.0001)). Similarly, type II fibre myonuclei number increased from baseline in both Y and O at 3 weeks and 6 weeks (younger: baseline 2.49 ± 0.14, 3 weeks; 3.31 ± 0.21 (P < 0.001), 6 weeks; 3.86 ± 0.29 (P < 0.0001); older: baseline 2.43 ± 0.12, 3 weeks; 3.37 ± 0.12 (P < 0.001), 6 weeks; 3.81 ± 0.15 (P < 0.0001)). DNA synthesis rates %.d(−1) exhibited a main effect of training but no age discrimination. Declines in myonuclei addition do not underlie impaired muscle growth capacity in older humans, supporting ribosomal and proteostasis impairments as we have previously reported.
format Online
Article
Text
id pubmed-9886697
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-98866972023-02-01 Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle Brook, Matthew S. Wilkinson, Daniel J. Tarum, Janelle Mitchell, Kyle W. Lund, Jonathan L. Phillips, Bethan E. Szewczyk, Nathaniel J. Kadi, Fawzi Greenhaff, Paul L. Smith, Ken Atherton, Philip J. GeroScience Article Ageing limits growth capacity of skeletal muscle (e.g. in response to resistance exercise), but the role of satellite cell (SC) function in driving this phenomenon is poorly defined. Younger (Y) (~ 23 years) and older (O) men (~ 69 years) (normal-weight BMI) underwent 6 weeks of unilateral resistance exercise training (RET). Muscle biopsies were taken at baseline and after 3-/6-week training. We determined muscle size by fibre CSA (and type), SC number, myonuclei counts and DNA synthesis (via D(2)O ingestion). At baseline, there were no significant differences in fibre areas between Y and O. RET increased type I fibre area in Y from baseline at both 3 weeks and 6 weeks (baseline: 4509 ± 534 µm(2), 3 weeks; 5497 ± 510 µm(2) P < 0.05, 6 weeks; 5402 ± 352 µm(2) P < 0.05), whilst O increased from baseline at 6 weeks only (baseline 5120 ± 403 µm(2), 3 weeks; 5606 ± 620 µm(2), 6 weeks; 6017 ± 482 µm(2) P < 0.05). However, type II fibre area increased from baseline in Y at both 3 weeks and 6 weeks (baseline: 4949 ± 459 µm(2), 3 weeks; 6145 ± 484 µm(2) (P < 0.01), 6 weeks; 5992 ± 491 µm(2) (P < 0.01), whilst O showed no change (baseline 5210 ± 410 µm(2), 3 weeks; 5356 ± 535 µm(2) (P = 0.9), 6 weeks; 5857 ± 478 µm(2) (P = 0.1). At baseline, there were no differences in fibre myonuclei number between Y and O. RET increased type I fibre myonuclei number from baseline in both Y and O at 3 weeks and 6 weeks with RET (younger: baseline 2.47 ± 0.16, 3 weeks; 3.19 ± 0.16 (P < 0.001), 6 weeks; 3.70 ± 0.29 (P < 0.0001); older: baseline 2.29 ± 0.09, 3 weeks; 3.01 ± 0.09 (P < 0.001), 6 weeks; 3.65 ± 0.18 (P < 0.0001)). Similarly, type II fibre myonuclei number increased from baseline in both Y and O at 3 weeks and 6 weeks (younger: baseline 2.49 ± 0.14, 3 weeks; 3.31 ± 0.21 (P < 0.001), 6 weeks; 3.86 ± 0.29 (P < 0.0001); older: baseline 2.43 ± 0.12, 3 weeks; 3.37 ± 0.12 (P < 0.001), 6 weeks; 3.81 ± 0.15 (P < 0.0001)). DNA synthesis rates %.d(−1) exhibited a main effect of training but no age discrimination. Declines in myonuclei addition do not underlie impaired muscle growth capacity in older humans, supporting ribosomal and proteostasis impairments as we have previously reported. Springer International Publishing 2022-09-09 /pmc/articles/PMC9886697/ /pubmed/36083436 http://dx.doi.org/10.1007/s11357-022-00651-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Brook, Matthew S.
Wilkinson, Daniel J.
Tarum, Janelle
Mitchell, Kyle W.
Lund, Jonathan L.
Phillips, Bethan E.
Szewczyk, Nathaniel J.
Kadi, Fawzi
Greenhaff, Paul L.
Smith, Ken
Atherton, Philip J.
Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle
title Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle
title_full Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle
title_fullStr Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle
title_full_unstemmed Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle
title_short Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle
title_sort neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886697/
https://www.ncbi.nlm.nih.gov/pubmed/36083436
http://dx.doi.org/10.1007/s11357-022-00651-y
work_keys_str_mv AT brookmatthews neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT wilkinsondanielj neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT tarumjanelle neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT mitchellkylew neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT lundjonathanl neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT phillipsbethane neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT szewczyknathanielj neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT kadifawzi neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT greenhaffpaull neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT smithken neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle
AT athertonphilipj neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle